Björkling F, Dahl A, Patkar S, Zundel M
Novo Nordisk A/S, Bagsvaerd, Denmark.
Bioorg Med Chem. 1994 Jul;2(7):697-705. doi: 10.1016/0968-0896(94)85020-8.
Ethyl hexylchlorophosphonate and analogues thereof were investigated as inhibitors of lipases. Both microbial and mammalian lipases were irreversibly inhibited. The inhibition could be monitored by p-nitrophenol release from the corresponding ethyl p-nitrophenyl hexylphosphonate inhibitor. Quantitative analysis of the data indicated that a 1:1 lipase-inhibitor complex was formed during inhibition. Enantioselective inhibition was found for the lipases derived from Candida antarctica and Rhizomucor miehei using pure enantiomers of ethyl p-nitrophenyl hexylphosphonate as inhibitors. Using the same inhibitor, reversed enantioselectivity was found for the protease alpha-chymotrypsin as compared to the two lipases.
研究了己基氯膦酸乙酯及其类似物作为脂肪酶抑制剂的情况。微生物脂肪酶和哺乳动物脂肪酶均受到不可逆抑制。这种抑制作用可通过从相应的对硝基苯基己基膦酸乙酯抑制剂中释放对硝基苯酚来监测。数据的定量分析表明,在抑制过程中形成了1:1的脂肪酶-抑制剂复合物。使用对硝基苯基己基膦酸乙酯的纯对映体作为抑制剂,发现对南极假丝酵母和米黑根毛霉来源的脂肪酶存在对映选择性抑制。使用相同的抑制剂,与两种脂肪酶相比,发现蛋白酶α-胰凝乳蛋白酶具有相反的对映选择性。